Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Paritaprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021 5 0
Remdesivir Approved by FDA Experimental Antiviral Jan/19/2021 49 4
Convalescent plasma Emergency use authorization Experimental Antiviral Jan/15/2021 27 5
Emetine Potential treatment - pre-clinical evidence Experimental Antiviral Jan/15/2021 6 0
Cannabidiol Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/14/2021 2 0
Quercetin Potential treatment - theoretical effect Natural product Antiviral Jan/12/2021 10 0
Cordycepin Potential treatment - theoretical effect Natural product Antiviral Dec/07/2020 1 0
MPI8 Potential treatment - pre-clinical evidence Experimental Antiviral Dec/07/2020 1 0
MPI5 Potential treatment - pre-clinical evidence Experimental Antiviral Dec/07/2020 1 0
Δ9-Tetrahydrocannabinol Potential treatment - pre-clinical evidence Used to treat other disease Other treatment Dec/05/2020 2 0